These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 7935373
1. Erythropoietin and interleukin-2 activate distinct JAK kinase family members. Barber DL, D'Andrea AD. Mol Cell Biol; 1994 Oct; 14(10):6506-14. PubMed ID: 7935373 [Abstract] [Full Text] [Related]
2. Mitogen-activated protein kinase plays an essential role in the erythropoietin-dependent proliferation of CTLL-2 cells. Sakamoto H, Kitamura T, Yoshimura A. J Biol Chem; 2000 Nov 17; 275(46):35857-62. PubMed ID: 10960479 [Abstract] [Full Text] [Related]
3. Erythropoietin activates Raf1 by an Shc-independent pathway in CTLL-EPO-R cells. Barber DL, Corless CN, Xia K, Roberts TM, D'Andrea AD. Blood; 1997 Jan 01; 89(1):55-64. PubMed ID: 8978277 [Abstract] [Full Text] [Related]
4. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3. Chin H, Wakao H, Miyajima A, Kamiyama R, Miyasaka N, Miura O. Blood; 1997 Jun 15; 89(12):4327-36. PubMed ID: 9192755 [Abstract] [Full Text] [Related]
5. Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo. Miura O, Nakamura N, Quelle FW, Witthuhn BA, Ihle JN, Aoki N. Blood; 1994 Sep 01; 84(5):1501-7. PubMed ID: 8068943 [Abstract] [Full Text] [Related]
6. Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways. Wakao H, Harada N, Kitamura T, Mui AL, Miyajima A. EMBO J; 1995 Jun 01; 14(11):2527-35. PubMed ID: 7781605 [Abstract] [Full Text] [Related]
7. Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells. Yamamura Y, Senda H, Kageyama Y, Matsuzaki T, Noda M, Ikawa Y. Mol Cell Biol; 1998 Mar 01; 18(3):1172-80. PubMed ID: 9488432 [Abstract] [Full Text] [Related]
8. A constitutively activated chimeric cytokine receptor confers factor-independent growth in hematopoietic cell lines. Shikama Y, Barber DL, D'Andrea AD, Sieff CA. Blood; 1996 Jul 15; 88(2):455-64. PubMed ID: 8695792 [Abstract] [Full Text] [Related]
9. Activation of the erythropoietin receptor is not required for internalization of bound erythropoietin. Beckman DL, Lin LL, Quinones ME, Longmore GD. Blood; 1999 Oct 15; 94(8):2667-75. PubMed ID: 10515870 [Abstract] [Full Text] [Related]
10. The box1 domain of the erythropoietin receptor specifies Janus kinase 2 activation and functions mitogenically within an interleukin 2 beta-receptor chimera. Jiang N, He TC, Miyajima A, Wojchowski DM. J Biol Chem; 1996 Jul 12; 271(28):16472-6. PubMed ID: 8663338 [Abstract] [Full Text] [Related]
11. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O, Ihle JN. Cell; 1993 Jul 30; 74(2):227-36. PubMed ID: 8343951 [Abstract] [Full Text] [Related]
12. Activated Ki-Ras complements erythropoietin signaling in CTLL-2 cells, inducing tyrosine phosphorylation of a 160-kDa protein. Yamamura Y, Noda M, Ikawa Y. Proc Natl Acad Sci U S A; 1994 Sep 13; 91(19):8866-70. PubMed ID: 7522324 [Abstract] [Full Text] [Related]
13. Activation of the erythropoietin receptor by the Friend spleen focus-forming virus gp55 glycoprotein induces constitutive protein tyrosine phosphorylation. Showers MO, Moreau JF, Linnekin D, Druker B, D'Andrea AD. Blood; 1992 Dec 15; 80(12):3070-8. PubMed ID: 1467516 [Abstract] [Full Text] [Related]
14. Identification of JAK protein tyrosine kinases as signaling molecules for prolactin. Functional analysis of prolactin receptor and prolactin-erythropoietin receptor chimera expressed in lymphoid cells. Dusanter-Fourt I, Muller O, Ziemiecki A, Mayeux P, Drucker B, Djiane J, Wilks A, Harpur AG, Fischer S, Gisselbrecht S. EMBO J; 1994 Jun 01; 13(11):2583-91. PubMed ID: 8013458 [Abstract] [Full Text] [Related]
15. Phosphorylation of erythropoietin receptors in the endoplasmic reticulum by pervanadate-mediated inhibition of tyrosine phosphatases. Cohen J, Altaratz H, Zick Y, Klingmüller U, Neumann D. Biochem J; 1997 Oct 15; 327 ( Pt 2)(Pt 2):391-7. PubMed ID: 9359406 [Abstract] [Full Text] [Related]
16. The extended box 2 subdomain of erythropoietin receptor is nonessential for Jak2 activation yet critical for efficient mitogenesis in FDC-ER cells. He TC, Jiang N, Zhuang H, Quelle DE, Wojchowski DM. J Biol Chem; 1994 Jul 15; 269(28):18291-4. PubMed ID: 8034573 [Abstract] [Full Text] [Related]
17. Receptors for interleukin (IL)-4 do not associate with the common gamma chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells. Murata T, Noguchi PD, Puri RK. J Biol Chem; 1995 Dec 22; 270(51):30829-36. PubMed ID: 8530527 [Abstract] [Full Text] [Related]
18. Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor. Miura O, Miura Y, Nakamura N, Quelle FW, Witthuhn BA, Ihle JN, Aoki N. Blood; 1994 Dec 15; 84(12):4135-41. PubMed ID: 7527668 [Abstract] [Full Text] [Related]
19. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways. Tong W, Zhang J, Lodish HF. Blood; 2005 Jun 15; 105(12):4604-12. PubMed ID: 15705783 [Abstract] [Full Text] [Related]
20. Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor. Miura Y, Miura O, Ihle JN, Aoki N. J Biol Chem; 1994 Nov 25; 269(47):29962-9. PubMed ID: 7961995 [Abstract] [Full Text] [Related] Page: [Next] [New Search]